Long-acting β2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified?
RC Tennant, EM Erin, PJ Barnes, TT Hansel - Current opinion in …, 2003 - Elsevier
Bronchodilators are the mainstay of therapy for patients with established chronic obstructive
pulmonary disease (COPD) but, at present, the majority of patients use short-acting agents …
pulmonary disease (COPD) but, at present, the majority of patients use short-acting agents …
Long-acting β 2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified?
RC Tennant, EM Erin, PJ Barnes, TT Hansel - Current Opinion in …, 2003 - infona.pl
Bronchodilators are the mainstay of therapy for patients with established chronic obstructive
pulmonary disease (COPD) but, at present, the majority of patients use short-acting agents …
pulmonary disease (COPD) but, at present, the majority of patients use short-acting agents …
Long-acting beta 2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified?
RC Tennant, EM Erin, PJ Barnes… - Current opinion in …, 2003 - pubmed.ncbi.nlm.nih.gov
Bronchodilators are the mainstay of therapy for patients with established chronic obstructive
pulmonary disease (COPD) but, at present, the majority of patients use short-acting agents …
pulmonary disease (COPD) but, at present, the majority of patients use short-acting agents …
Long-acting beta 2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified?
RC Tennant, EM Erin, PJ Barnes… - Current Opinion in …, 2003 - europepmc.org
Bronchodilators are the mainstay of therapy for patients with established chronic obstructive
pulmonary disease (COPD) but, at present, the majority of patients use short-acting agents …
pulmonary disease (COPD) but, at present, the majority of patients use short-acting agents …